Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Duke Clinical Research Institute, Durham, North Carolina.
Pacing Clin Electrophysiol. 2020 May;43(5):503-510. doi: 10.1111/pace.13916. Epub 2020 May 8.
A low electrocardiogram (ECG) lead one ratio (LOR) of the maximum positive/negative QRS amplitudes is associated with lower left ventricular ejection fraction (LVEF) and worse outcomes in left bundle branch block (LBBB); however, the impact of LOR on cardiac resynchronization therapy (CRT) outcomes is unknown. We compared clinical outcomes and echocardiographic changes after CRT implantation by LOR.
Consecutive CRT-defibrillator recipients with LBBB implanted between 2006 and 2015 at Duke University Medical Center were included (N = 496). Time to heart transplant, left ventricular assist device (LVAD) implantation, or death was compared among patients with LOR <12 vs ≥12 using Cox-proportional hazard models. Changes in LVEF and LV volumes after CRT were compared by LOR.
Baseline ECG LOR <12 was associated with an adjusted hazard ratio (HR) of 1.69 (95% CI: 1.12-2.40, P = .01) for heart transplant, LVAD, or death. Patients with LOR <12 had less reduction of LV end diastolic volume (ΔLVEDV -4 ± 21 vs -13 ± 23%, P = .04) and LV end systolic volume (ΔLVESV -9 ± 27 vs -22 ± 26%, P = .03) after CRT. In patients with QRS duration (QRSd) ≥150 ms, LOR <12 was associated with an adjusted HR of 2.01 (95% CI 1.21-3.35, P = .008) for heart transplant, LVAD, or death, compared with LOR ≥12.
Baseline ECG LOR <12 portends worse outcomes after CRT implantation in patients with LBBB, specifically among those with QRSd ≥150 ms. This ECG ratio may identify patients with a class I indication for CRT implantation at high risk for poor postimplantation outcomes.
心电图(ECG)最大正向/负向 QRS 幅度的导联 1 比值(LOR)较低与左束支传导阻滞(LBBB)患者的左心室射血分数(LVEF)较低和预后较差相关;然而,LOR 对心脏再同步治疗(CRT)结果的影响尚不清楚。我们比较了 LOR 指导下 CRT 植入后的临床结果和超声心动图变化。
纳入 2006 年至 2015 年期间在杜克大学医学中心植入 CRT 除颤器的连续 LBBB 患者(N=496)。使用 Cox 比例风险模型比较 LOR<12 与 LOR≥12 的患者之间发生心脏移植、左心室辅助装置(LVAD)植入或死亡的时间。比较 CRT 后 LVEF 和 LV 容积的变化。
基线心电图 LOR<12 与心脏移植、LVAD 或死亡的调整后风险比(HR)为 1.69(95%CI:1.12-2.40,P=0.01)。LOR<12 的患者 LV 舒张末期容积(ΔLVEDV -4±21% 与 -13±23%,P=0.04)和 LV 收缩末期容积(ΔLVESV -9±27% 与 -22±26%,P=0.03)减少较少。在 QRS 时限(QRSd)≥150ms 的患者中,与 LOR≥12 的患者相比,LOR<12 与心脏移植、LVAD 或死亡的调整后 HR 为 2.01(95%CI 1.21-3.35,P=0.008)。
在 LBBB 患者中,基线 ECG LOR<12 预示着 CRT 植入后的预后较差,尤其是 QRSd≥150ms 的患者。这种 ECG 比值可以识别出具有 CRT 植入一级适应证且植入后结局较差风险较高的患者。